← All organizations
Centre Henri Becquerel
Academic/HospitalWebsite ↗
Also known as: Centre Henri Becquerel | Centre Henri Becquerel, 76038 Rouen, France | Centre Henri Becquerel de Rouen | Centre Henri Becquerel, ROUEN | Centre Henri Becquerel, Rouen, France | Centre Henri Becquerel, Rouen, France - LYSA
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2004Last known activity
Oct 31, 2019
Timeline
1960s
- Jan 1, 1967
Centre Henri Becquerel— Founded
Drugs by trial phase (33 distinct, 14 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Bone Marrow Diseases
- Bone Neoplasms
- Head and Neck Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Recurrence
Recent trials (20)
- NCT04113226CollaboratorPhase 2Oct 31, 2019
- NCT04113226Overall official - principal investigatorPhase 2Oct 31, 2019
- NCT03599960CollaboratorPhase 2Sep 30, 2018
- NCT03594149Overall official - principal investigatorPhase 3Jul 18, 2018
- NCT03594149Lead sponsorPhase 3Jul 18, 2018
- NCT02741388Study chairPhase 1Oct 1, 2016
- NCT02426697Overall official - principal investigatorPhase 3May 1, 2015
- NCT02426697Lead sponsorPhase 3May 1, 2015
- NCT02197221Overall official - principal investigatorPhase 3Jan 1, 2015
- NCT02317393Overall official - principal investigatorPhase 2Dec 31, 2014
- NCT02317393OfficialPhase 2Dec 31, 2014
- NCT02272166CollaboratorPhase 4Nov 1, 2014
- NCT01956695CollaboratorPhase 2Sep 1, 2013
- NCT01393756CollaboratorPhase 2Dec 1, 2010
- NCT01237483Overall official - principal investigatorPhase 2Oct 1, 2010
Details
- Founded
- Rouen, FR Jan 1, 1967
- Last known activity
- Oct 31, 2019